DJIA 16,804.71 -238.19 -1.40%
NASDAQ 4,422.09 -71.31 -1.59%
S&P 500 1,946.16 -26.13 -1.32%
market minute promo

Vertex Pharmaceuticals (NASDAQ: VRTX)

107.25 -5.06 (-4.51%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

VRTX $107.25 -4.51%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $112.88
Previous Close $112.31
Daily Range $105.27 - $112.89
52-Week Range $58.06 - $116.88
Market Cap $25.5B
P/E Ratio -56.44
Dividend (Yield) $0.00 (0.0%)
Volume 2,743,632
Average Daily Volume 1,675,405
Current FY EPS -$2.81

Sector

Healthcare

Industry

Drugs

Vertex Pharmaceuticals (VRTX) Description

The Company is in the business of discovering, developing and commercializing small molecule drugs for the treatment of serious diseases. Website: http://www.vrtx.com/

News & Commentary Rss Feed

Has Gilead Sciences, Inc.'s Star Drug Already Peaked?

Prescriptions of Gilead Sciences' hepatitis C drug Sovaldi peaked, but sales will pick up after the new combination product is approved.

Nasdaq 100 Movers: ADP, VOD

Nasdaq 100 Movers: ADP, VOD

H.C. Wainwright Highlights Its Top Picks Ahead Of NACFC 2014

Why J&J Expands Antiviral Franchise but Doesn't Buy Achillion, Novavax

3 Drugs Stocks Driving The Industry Higher

Fast Money Picks For September 26 - Pfizer Inc., The Dow Chemical Company And More

Trade-Ideas: Vertex Pharmaceuticals (VRTX) Is Today's Post-Market Leader Stock

Stock Market News for September 25, 2014 - Market News

5 Orphan Drug Biotech Stocks to Buy With Big Upside Potential

Biotech Stock Roundup: Auxilium an Acquisition Target, Amgen Submits another BLA - Analyst Blog

Biotech Stock Roundup: Auxilium an Acquisition Target, Amgen Submits another BLA - Analyst Blog

See More VRTX News...

VRTX's Top Competitors

VRTX $107.25 (-4.51%)
Current stock: VRTX
AMGN $138.82 (-1.17%)
Current stock: AMGN
GILD $105.59 (-0.81%)
Current stock: GILD
CELG $93.43 (-1.42%)
Current stock: CELG